Korean Circulation Journal

  • 제41권7호
  • /
  • Pages.417-420
  • /
  • 2011
  • /
  • 1738-5520(pISSN)
  • /
  • 1738-5555(eISSN)
대한심장학회 (The Korean Society of Cardiology)
권호 표지
DOI QR코드

DOI QR Code

Very Late Stent Thrombosis in a Drug-Eluting Stent due to Interruption of Anti-Platelet Agents in Patients With Acute Myocardial Infarction and Thrombocytosis

  • Choi, Hong-Sang (The Heart Center of Chonnam National University Hospital, Cardiovascular Research Institute of Chonnam National University) ;
  • Jeong, Myung-Ho (The Heart Center of Chonnam National University Hospital, Cardiovascular Research Institute of Chonnam National University) ;
  • Seo, Il-Kook (The Heart Center of Chonnam National University Hospital, Cardiovascular Research Institute of Chonnam National University) ;
  • Lee, Min-Goo (The Heart Center of Chonnam National University Hospital, Cardiovascular Research Institute of Chonnam National University) ;
  • Ko, Jum-Suk (The Heart Center of Chonnam National University Hospital, Cardiovascular Research Institute of Chonnam National University) ;
  • Park, Keun-Ho (The Heart Center of Chonnam National University Hospital, Cardiovascular Research Institute of Chonnam National University) ;
  • Sim, Doo-Sun (The Heart Center of Chonnam National University Hospital, Cardiovascular Research Institute of Chonnam National University) ;
  • Yoon, Nam-Sik (The Heart Center of Chonnam National University Hospital, Cardiovascular Research Institute of Chonnam National University) ;
  • Kim, Kye-Hun (The Heart Center of Chonnam National University Hospital, Cardiovascular Research Institute of Chonnam National University) ;
  • Park, Hyung-Wook (The Heart Center of Chonnam National University Hospital, Cardiovascular Research Institute of Chonnam National University) ;
  • Hong, Young-Joon (The Heart Center of Chonnam National University Hospital, Cardiovascular Research Institute of Chonnam National University) ;
  • Kim, Ju-Han (The Heart Center of Chonnam National University Hospital, Cardiovascular Research Institute of Chonnam National University) ;
  • Ahn, Young-Keun (The Heart Center of Chonnam National University Hospital, Cardiovascular Research Institute of Chonnam National University) ;
  • Cho, Jeong-Gwan (The Heart Center of Chonnam National University Hospital, Cardiovascular Research Institute of Chonnam National University) ;
  • Park, Jong-Chun (The Heart Center of Chonnam National University Hospital, Cardiovascular Research Institute of Chonnam National University) ;
  • Kang, Jung-Chaee (The Heart Center of Chonnam National University Hospital, Cardiovascular Research Institute of Chonnam National University)
  • 발행 : 2011.07.30
⟨ 이전 논문 다음 논문 ⟩

초록

Stent thrombosis is a fatal complication in patients who have undergone percutaneous coronary intervention, and discontinuation of anti-platelet agent is a major risk factor of stent thrombosis. We report a rare case of very late stent thrombosis (VLST) following discontinuation of anti-platelet agents in a patient who experienced acute myocardial infarction and essential thrombocytosis. She had undergone implantation of a drug eluting stent (DES) and a bare metal stent (BMS) two and half years prior to her presentation. VLST developed in DES, not in BMS, following interruption of anti-platelet therapy.

키워드

참고문헌

  1. Colombo A, Drzewiecki J, Banning A, et al. Randomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxel-eluting stents for coronary artery lesions. Circulation 2003; 108:788-94. https://doi.org/10.1161/01.CIR.0000086926.62288.A6
  2. Serruys PW, Degertekin M, Tanabe K, et al. Intravascular ultrasound findings in the multicenter, randomized, double-blind RAVEL (RAndomized study with the sirolimus-eluting VElocity balloon-expandable stent in the treatment of patients with de novo native coronary artery Lesions) trial. Circulation 2002;106:798-803. https://doi.org/10.1161/01.CIR.0000025585.63486.59
  3. Zhang F, Ge J, Qian J, et al. Sirolimus-eluting stents in real-world patients with ST-segment elevation acute myocardial infarction. Int Heart J 2007;48:303-11. https://doi.org/10.1536/ihj.48.303
  4. Daemen J, Wenaweser P, Tsuchida K, et al. Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study. Lancet 2007;369:667-78. https://doi.org/10.1016/S0140-6736(07)60314-6
  5. Kastrati A, Mehilli J, Pache J, et al. Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents. N Engl J Med 2007;356: 1030-9. https://doi.org/10.1056/NEJMoa067484
  6. Pinto Slottow TL, Steinberg DH, Roy PK, et al. Observations and outcomes of definite and probable drug-eluting stent thrombosis seen at a single hospital in a four-year period. Am J Cardiol 2008;102:298-303. https://doi.org/10.1016/j.amjcard.2008.03.055
  7. Spaulding C, Daemen J, Boersma E, Cuttlip DE, Serruys PW. A pooled analysis of data comparing sirolimus-eluting stents with bare-me-tal stents. N Engl J Med 2007;356:989-97. https://doi.org/10.1056/NEJMoa066633
  8. Stone GW, Moses JW, Ellis SG, et al. Safety and efficacy of sirolimus-and paclitaxel-eluting coronary stents. N Engl J Med 2007;356:998-1008. https://doi.org/10.1056/NEJMoa067193
  9. Kim SS, Jeong MH, Sim DS, et al. Very late thrombosis of a drug-eluting stent after discontinuation of dual antiplatelet therapy in a patient treated with both drug-eluting and bare-metal stents. Korean Circ J 2009;39:205-8. https://doi.org/10.4070/kcj.2009.39.5.205
  10. Awata M, Kotani J, Uematsu M, et al. Serial angioscopic evidence of incomplete neointimal coverage after sirolimus-eluting stent implantation: comparison with bare-metal stents. Circulation 2007;116: 910-6. https://doi.org/10.1161/CIRCULATIONAHA.105.609057
  11. Takano M, Yamamoto M, Xie Y, et al. Serial long-term evaluation of neointimal stent coverage and thrombus after sirolimus-eluting stent implantation by use of coronary angioscopy. Heart 2007;93:1353-6. https://doi.org/10.1136/hrt.2007.132555
  12. Iakovou I, Schmidt T, Bonizzoni E, et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 2005;293:2126-30. https://doi.org/10.1001/jama.293.17.2126
  13. Kuchulakanti PK, Chu WW, Torguson R, et al. Correlates and longterm outcomes of angiographically proven stent thrombosis with sirolimus- and paclitaxel-eluting stents. Circulation 2006;113:1108-13. https://doi.org/10.1161/CIRCULATIONAHA.105.600155
  14. Park DW, Park SW, Park KH, et al. Frequency of and risk factors for stent thrombosis after drug-eluting stent implantation during longterm follow-up. Am J Cardiol 2006;98:352-6. https://doi.org/10.1016/j.amjcard.2006.02.039
  15. Veitch AM, Baglin TP, Gershlick AH, et al. Guidelines for the management of anticoagulant and antiplatelet therapy in patients undergoing endoscopic procedures. Gut 2008;57:1322-9. https://doi.org/10.1136/gut.2007.142497
  16. Zuckerman MJ, Hirota WK, Adler DG, et al. ASGE guideline: the management of low-molecular-weight heparin and nonaspirin antiplatelet agents for endoscopic procedures. Gastrointest Endosc 2005;61: 189-94. https://doi.org/10.1016/S0016-5107(04)02392-2
  17. Tefferi A, Fonseca R, Pereira DL, Hoagland HC. A long-term retrospective study of young women with essential thrombocythemia. Mayo Clin Proc 2001;76:22-8. https://doi.org/10.4065/76.1.22
  18. Turgut T, Harjai KJ, Edupuganti R, et al. Acute coronary occlusion and in-stent thrombosis in a patient with essential thrombocythemia. Cathet Cardiovasc Diagn 1998;45:428-33. https://doi.org/10.1002/(SICI)1097-0304(199812)45:4<428::AID-CCD19>3.0.CO;2-E
  19. Watanabe T, Fujinaga H, Ikeda Y, et al. Acute myocardial infarction in a patient with essential thrombocythemia who underwent successful stenting: a case report. Angiology 2005;56:771-4. https://doi.org/10.1177/000331970505600616
  20. Kumagai N, Mitsutake R, Miura S, et al. Acute coronary syndrome associated with essential thrombocythemia. J Cardiol 2009;54:485-9. https://doi.org/10.1016/j.jjcc.2009.03.001

피인용 문헌

  1. A Case of Recurrent Stent Thrombosis in a Patient with Essential Thrombocythemia vol.83, pp.1, 2011, https://doi.org/10.3904/kjm.2012.83.1.101
  2. Prinzmetal Angina in a Young Patient with Essential Thrombocythemia, After Anagrelide Initiation - Case Report and Literature Review vol.24, pp.1, 2011, https://doi.org/10.2478/arsm-2018-0009
  3. Mechanical properties and degradation of drug eluted bioresorbable vascular scaffolds prepared by three-dimensional printing technology vol.30, pp.7, 2011, https://doi.org/10.1080/09205063.2019.1586303
  4. Predictors of stent thrombosis and their implications for clinical practice vol.16, pp.4, 2011, https://doi.org/10.1038/s41569-018-0118-5